The Beck Depression Inventory requires modification in scoring before use in a haemodialysis population in the UK

Donna Grant1, Michael K Almond, Alison Newnham

  • 1Department of General Adult Psychiatry, Brentwood, UK.

Insights

The Beck Depression Inventory (BDI) overdiagnoses depression in end-stage renal disease (ESRD) patients on haemodialysis (HD). This study establishes a new BDI cut-off score for more accurate depression detection in this population.

Area of Science:

  • Nephrology
  • Psychiatry
  • Clinical Psychology

Background:

  • High rates of depression exist in end-stage renal disease (ESRD) patients undergoing haemodialysis (HD).
  • Shared symptoms between depression and medical conditions complicate accurate diagnosis.
  • Reliable depression diagnosis is crucial for effective psychiatric management in ESRD patients.

Purpose of the Study:

  • To validate the Beck Depression Inventory (BDI) for detecting depression in UK patients on HD.
  • To compare BDI results against a structured psychiatric interview using ICD-10 classification.
  • To establish appropriate BDI cut-off scores for the HD population.

Main Methods:

  • 57 eligible patients on HD for over 3 months completed the self-reported BDI.
  • Patients with pre-existing psychiatric conditions or recent major illnesses were excluded.
  • A psychiatrist conducted a clinical interview within a week to diagnose depression based on ICD-10 criteria.

Main Results:

  • The BDI yielded higher and more severe depression scores compared to the ICD-10 classification.
  • Agreement was found in 30 cases, while 27 showed higher BDI scores.
  • All 7 patients diagnosed with depression by interview were identified by the BDI, though 2 showed inflated scores.

Conclusions:

  • The standard BDI cut-off score overdiagnoses depression in HD patients.
  • A specific BDI cut-off score is proposed for more reliable major depression detection in this population.
  • Undiagnosed depression remains prevalent in HD patients without prior psychiatric diagnoses.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...